The FDA approved Lerochol, a monthly PCSK9 inhibitor, for adults with hypercholesterolemia to reduce LDL-C levels alongside diet and exercise.
Introduction Refractory headache is a common and frequently disabling disorder, affecting 2–12 million patients each year in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results